FANJ
CLDX icon

Financial Architects (New Jersey)’s Celldex Therapeutics CLDX Stock Holding History

Financial Architects (New Jersey)’s Portfolio CLDX Stock Details CLDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-149
Closed -$1K – 1234
2019
Q1 		$1K Sell
149
-1
-0.7% -$5 ﹤0.01% 1357
2018
Q4 		$0 Sell
150
-60
-29% -$295 ﹤0.01% 1354
2018
Q3 		$1K Hold
210
– – ﹤0.01% 1357
2018
Q2 		$2K Sell
210
-20
-9% -$267 ﹤0.01% 1205
2018
Q1 		$8K Hold
230
– – ﹤0.01% 1140
2017
Q4 		$10K Hold
230
– – ﹤0.01% 1147
2017
Q3 		$10K Buy
230
+40
+21% +$1.5K ﹤0.01% 1118
2017
Q2 		$7K Buy
190
+14
+8% +$619 ﹤0.01% 1204
2017
Q1 		$10K Buy
176
+96
+120% +$5K ﹤0.01% 1131
2016
Q4 		$4K Buy
80
+20
+33% +$1.14K ﹤0.01% 1177
2016
Q3 		$4K Hold
60
– – ﹤0.01% 1184
2016
Q2 		$4K Buy
+60
New +$3.81K ﹤0.01% 1161

Other funds holding CLDX

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CAM
Cresset Asset Management Chicago, Illinois $23.1B AUM 27.04% 1-Year Est. Return
MG
Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
TCMG
TSP Capital Management Group Summit, New Jersey $410M AUM 71.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return